2007
DOI: 10.1016/j.neuropharm.2006.11.003
|View full text |Cite
|
Sign up to set email alerts
|

ORL1 receptor-mediated down-regulation of mPER2 in the suprachiasmatic nucleus accelerates re-entrainment of the circadian clock following a shift in the environmental light/dark cycle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 49 publications
1
9
0
Order By: Relevance
“…For example, OPRL1 (also known as nociception receptor) is an opiate receptor that is strongly expressed in the mouse SCN where it binds nociception/orphanin FQ, which suppresses 88% of SCN neurons (41). Moreover, OPRL1 activation down-regulates PER2 in the SCN and accelerates reentrainment of rhythms following a shift in the light-dark cycle (42). The importance of the rhythms in this protein in BA11 and BA47 function in human brain is not known.…”
Section: Discussionmentioning
confidence: 99%
“…For example, OPRL1 (also known as nociception receptor) is an opiate receptor that is strongly expressed in the mouse SCN where it binds nociception/orphanin FQ, which suppresses 88% of SCN neurons (41). Moreover, OPRL1 activation down-regulates PER2 in the SCN and accelerates reentrainment of rhythms following a shift in the light-dark cycle (42). The importance of the rhythms in this protein in BA11 and BA47 function in human brain is not known.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to VIP and AVP, which appear to play key roles in generating and maintaining circadian timing, other neuropeptides modify the activity of the SCN (Teshima et al. , 2005; Miyakawa et al. , 2007).…”
Section: Discussionmentioning
confidence: 99%
“…, 1996; Maywood et al. , 2007; Miyakawa et al. , 2007; Morin, 2007; Butler & Silver, 2009; Welsh et al.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This receptor is expressed in the rat and mouse SCN (Allen et al, 1999;Houtani et al, 2000), and systemic injection of W-212393, a NOP-1 agonist, dose dependently induces phase advances in body temperature rhythms in rats, and in locomotor activity rhythms in mice, when administered during the midsubjective day (Miyakawa et al, 2007;Teshima et al, 2005). However, injection of OFQ/N into the hamster SCN appears to be without effect (Allen et al, 1999).…”
Section: Other Mediatorsmentioning
confidence: 99%